The "Portugal Existing & Upcoming Data Center Portfolio" report has been added to ResearchAndMarkets.com's offering. Portugal hosts around 12 existing data centers, with Lisbon dominating the region.

Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "Portugal Existing & Upcoming Data Center Portfolio" report has been added to ResearchAndMarkets.com's offering. Portugal hosts around 12 existing data ...

Tel Aviv, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace ...

This repository contains the code and documentation for a project that focuses on predicting stock market prices using LSTM models and optimizing a portfolio based on these predictions. Objective: ...

Pineapple Financial (PAPL), a Toronto-based fintech listed on NYSE American, has launched a mortgage tokenization platform and begun converting loan records into digital assets on the Injective ...

President, CEO & Director Hong Hou stated the company "made solid progress again this quarter, driving strong sequential and year-over-year revenue and earnings growth, aligning our data center road ...

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key ...

Berkshire Hathaway's largest stock holding remains Apple, a company that has incorporated AI into its popular tech products. Buffett has also bought shares of insurance giant Chubb and payments leader ...

BlackRock’s Global Infrastructure Partners and Spanish construction company ACS said they agreed to form a joint venture to develop data centers, with an initial portfolio valued at about 2 billion ...

Construction profit margins are notoriously thin. One underperforming project can erase a portfolio’s gains. For executives, this fragility brings enormous pressure, yet they’re often the last to know ...

Clinical and pharmacogenetic data confirm the safety and suitability of TLC-6740 for use in conjunction with GLP-1 receptor agonists and proton pump inhibitors across genomic profiles Preclinical ...